Skip to content
value.today

C4 Therapeutics, Inc.

Total raised
$70 M
1 round on record
Latest round
$70 M
Dec 2015
First round on record
Dec 2015
Today
Went public
See the company page

C4 Therapeutics, Inc. is listed today as C4 Therapeutics, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of C4 Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2015$70 MNo. 1$50 to $250 million

C4 Therapeutics, Inc.: Raise no. 1, Dec 2015

Investors in this round

55 investors had bought by the notice of Jan 11, 2016: 55 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for C4 Therapeutics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$70 M of $73 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Fisherman · Executive Officer, Director
  • Marc Cohen · Executive Officer, Director
  • Alain Cohen · Director
  • Bihua M. Chen · Director
  • Bruce M. Downey · Director
  • Elena M. Prokupets · Director
  • Jay M. Eastman · Director
  • Kenneth M. Anderson · Director
  • Malcolm S. Salter · Director
  • Miles M. Stuchin · Director
  • Ronald W. Kaiser · Director
  • William M. Scalzulli · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Marc Cohen, President. Source: SEC Form D, newest notice filed Jan 11, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • C4 Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2016).

    SEC Form D · Jan 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2016

That is all the official record says: C4 Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of C4 Therapeutics, Inc. are on record.

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in C4 Therapeutics, Inc.
InvestorKindAmountRoundRoleSource
Bruce DowneyPersonnot statednot statedHeld Series A and B preferred stock, director (Form 3, 2020)SEC Form 3
Kenneth Carl AndersonPersonnot statednot statedHeld Series A preferred stock, director (Form 3, 2020)SEC Form 3
Malcolm SalterPersonnot statednot statedHeld Series A and B preferred stock, director (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 55 investors.

Largest shareholders today

Institutions holding C4 Therapeutics, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by C4 Therapeutics, Inc.
NameRoleNamed in
Jason FishermanExecutive officerJan 2016
Marc CohenExecutive officerJan 2016
Alain CohenDirectorJan 2016
Bihua M. ChenDirectorJan 2016
Bruce M. DowneyDirectorJan 2016
Elena M. ProkupetsDirectorJan 2016
Jason FishermanDirectorJan 2016
Jay M. EastmanDirectorJan 2016
Kenneth M. AndersonDirectorJan 2016
Malcolm S. SalterDirectorJan 2016
Marc CohenDirectorJan 2016
Miles M. StuchinDirectorJan 2016
Ronald W. KaiserDirectorJan 2016
William M. ScalzulliDirectorJan 2016

About

Company in Watertown, United States.

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.